{
    "Trade/Device Name(s)": [
        "Tina-Quant Albumin Gen. 2",
        "Albumin Gen. 2 - cobas c 311 urine assay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K113072",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101203"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCF"
    ],
    "Summary Letter Date": "March 29, 2012",
    "Summary Letter Received Date": "April 2, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5040"
    ],
    "Regulation Name(s)": [
        "Albumin immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Albumin"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c 311 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Tina-Quant Albumin Gen. 2 immunoturbidimetric assay for quantitative albumin measurement in urine using the Roche/Hitachi cobas c 311 analyzer",
    "Indications for Use Summary": "Quantitative in vitro determination of albumin in human urine on the Roche/Hitachi cobas c 311 analyzer to aid in the diagnosis of kidney and intestinal diseases",
    "fda_folder": "Immunology"
}